Scientists open first chapter of the book of life with decoding of human chromosome

An international team of researchers has passed a scientific milestone by deciphering, for the first time, the complete genetic code of a human chromosome and revealing the existence of hundreds of genes previously unknown in humans.

Scientists open first chapter of the book of life with decoding of human chromosome

An international team of researchers has passed a scientific milestone by deciphering, for the first time, the complete genetic code of a human chromosome and revealing the existence of hundreds of genes previously unknown in humans.

Reported in this week's edition of Nature (2nd December), researchers from the Wellcome Trust-funded Sanger Centre near Cambridge, Keio University in Japan and US laboratories at the University of Oklahoma and Washington University, St. Louis have succeeded in writing down the 34 million 'letters' that make up the entire sequence that contains all the protein coding genes of Chromosome 22. This is the first human chromosome sequence to be completed. It has revealed 679 genes, of which 55 per cent were previously unknown in humans, and improvements in software for finding genes may enable us to find even more. The work gives scientists a real insight into the way genes are arranged along a strand of DNA and how they might be controlled, paving the way for huge advances in medical diagnosis and treatment.

There are 23 pairs of chromosomes in the human genome. Each chromosome consists of a single linear molecule of DNA, which is composed of four chemical bases represented by the letters A (adenine), T(thymine), G (guanine) and C(cytosine). It is the order, or "sequence", and context of these letters which determines how our bodies are made, and our predisposition to certain diseases.

Previous research has already revealed that chromosome 22 is implicated in the workings of the immune system, congenital heart disease, schizophrenia, mental retardation and several cancers including leukaemia. The availability of the DNA sequence will revolutionise the future of research on these diseases, and the function of other genes on Chromosome 22.

The initiative forms part of the Human Genome Project; an international collaboration in which scientists at the Sanger Centre together with colleagues in the US, Japan, France, Germany and China are sequencing the entire human genome.

Work continues to complete the estimated 3 billion letters that make up the whole of the human genome, with a first working draft available by Spring 2000, and the highly accurate, finished form before 2003. One third of the genome has already been completed, most of which has been done this year, and the data has been deposited in public databases.

"This is the first time that we have been able to see the organisation of a chromosome at the base-pair level. This immediately suggests new experiments and avenues of research which can be pursued."

Dr Ian Dunham at the Sanger Centre who led the international chromosome 22 team

"For the first time the scientific world knows what a whole human chromosome looks like and the knowledge that we derive from this discovery will be used for centuries to come. It is a remarkable achievement that will change the way in which diseases and other medical conditions are diagnosed and treated in future."

Dr Michael Dexter, Director of the Wellcome Trust commented

The sequence of chromosome 22 includes 298 genes previously unknown in man, which are being released without the constraints of patents and fees. The fact that all of this information is now freely available for scientists to use, is of major importance, if the knowledge of our genetic make-up is to be used for the good of mankind.

"Until now, the ability to sequence an entire chromosome was just hypothetical. No one knew if there would be insurmountable problems that prevented the assembly. Having done this for chromosome 22 tells us we will be able finish the human genome in another two or three years."

Dr Francis Collins, Director of the National Genome Research Institute at the National Institutes of Health, the US partners in the publicly funded Human Genome Project

Notes to Editors
  1. The principal scientists involved in the sequencing of chromosome 22 are Dr. Ian Dunham, Senior Research Fellow, The Sanger Centre, Hinxton, Cambridge, UK; (Dr.) Bruce Roe, University of Oklahoma, Norman, USA; (Dr.) Nobuyoshi Shimizu, Keio University School of Medicine, Tokyo, Japan.
  2. The Wellcome Trust has committed £210 million towards the Human Genome Project, enabling one third of the work to be completed at the Sanger Centre, the world's largest genome sequencing centre. The USA is funding the majority of the programme through the National Human Genome Research Institute (NHGRI) and the US Department of Energy. Other countries contributing to the project are France, Germany, Japan and China.
  3. The Wellcome Trust and the Sanger Centre have been at the forefront of efforts to keep the human sequence data in the public domain and to allow equal access by all to our common genetic heritage. The Trust believes that any attempts to patent this valuable research tool for commercial gain will hinder the development of future healthcare.
  4. The Wellcome Trust is the world's largest medical research charity with an annual spend of £400 million. The Trust supports more than 3,000 researchers, at 300 locations, in 30 different countries - laying the foundations for the development of new and better treatment of diseases in the next century and helping to maintain the UK's reputation as one of the world's leading scientific nations. As well as funding major initiatives in the public understanding of science, the Wellcome Trust is the country's leading supporter of research into the history of medicine.
Contact the Press Office

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Emily Mobley, Media Officer

Tel +44 (0)1223 496 851

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7900 607793

Recent News

Low doses of radiation promote cancer-capable cells
New research in mice helps to understand the risks around exposure to low doses of radiation, such as CT scans and x-rays
Chan Zuckerberg Initiative boosts Human Cell Atlas research at the Sanger Institute
Seed Networks projects will focus on specific tissues, such as the thymus, lung, liver, kidney and immune system
Widely-available antibiotics could be used in the treatment of ‘superbug’ MRSA
Genomic analysis shows that a significant number of strains are susceptible to penicillin combined with clavulanic acid